Tardive Dyskinesia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Individuals diagnosed with schizophrenia (DSV-V) and clinical presentation of Tardive Dyskinesia (Schooler-Kane criteria), both genders, aged between 18 and 65 years, with no changes in drug treatment in the last 4 weeks.
Exclusion criteria
Exclusion criteria: Pregnant, presence of skin disease in the electrode region, patients with relevant psychiatric comorbidity (chemical dependence, suicide risk), neurological diseases (epilepsy, stroke, dementia) and clinical diseases (malignant tumors, infections, cardiac).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of Tardive Dyskinesia, verified by the Abnormal Involuntary Movement Scale (AIMS), based on a score reduction when compared to baseline evaluation (T0). | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of symptoms in schizophrenia and global clinical improvement, verified by the The Positive and Negative Syndrome Scale (PANSS) and The Clinical Global Impression (CGI), based on a score reduction when compared to baseline evaluation (T0). | — |
Countries
Brazil
Contacts
Faculdade de Medicina da Universidade de Brasília - FM/UnB